Skip to content
10-K

Annual Report

ACCUSTEM SCIENCES, INC. ACUT

0001493152-26-016559

← back to feed
Filed
Apr 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 14, 2026 16.07M sh
Shares Diluted FY 2025 · Dec 31, 2025 15.23M sh
Shares Diluted FY 2025 · Dec 31, 2024 11.44M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$850.39K
Operating Cash Flow FY 2025 · Dec 31, 2024 −$664.07K
Stockholders Equity FY 2025 · Dec 31, 2025 −$3.4M
Stockholders Equity FY 2025 · Dec 31, 2024 −$3.31M
Stockholders Equity FY 2025 · Dec 31, 2023 −$2.11M
Current Liabilities FY 2025 · Dec 31, 2025 $4.95M
Current Liabilities FY 2025 · Dec 31, 2024 $3.36M
Total Liabilities FY 2025 · Dec 31, 2025 $4.95M
Total Liabilities FY 2025 · Dec 31, 2024 $3.36M
Current Assets FY 2025 · Dec 31, 2025 $49.45K
Current Assets FY 2025 · Dec 31, 2024 $50.43K
Total Assets FY 2025 · Dec 31, 2025 $1.55M
Total Assets FY 2025 · Dec 31, 2024 $50.85K
Eps Diluted FY 2025 · Dec 31, 2025 −$0.12
Eps Diluted FY 2025 · Dec 31, 2024 −$0.13
Eps Basic FY 2025 · Dec 31, 2025 −$0.12
Eps Basic FY 2025 · Dec 31, 2024 −$0.13
Sga Expense FY 2025 · Dec 31, 2025 $1.48M
Sga Expense FY 2025 · Dec 31, 2024 $1.37M
Rd Expense FY 2025 · Dec 31, 2025 $281.01K
Rd Expense FY 2025 · Dec 31, 2024 $138.32K
Net Income FY 2025 · Dec 31, 2025 −$1.76M
Net Income FY 2025 · Dec 31, 2024 −$1.51M
Operating Income FY 2025 · Dec 31, 2025 −$1.76M
Operating Income FY 2025 · Dec 31, 2024 −$1.51M